Improving cancer outcomes: Risks and opportunities for the life insurance sector
Cancer research breakthroughs will have profound impacts on the life insurance industry.
Brad Heltemes, MD, is vice president and medical director of research and development at Munich Re Life US and has 25 years of experience in insurance medicine. Contact him at brad.heltemes@innfeedback.com.
